Last reviewed · How we verify
Placebo [Ambulatory Cohort] only — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo [Ambulatory Cohort] only (Placebo [Ambulatory Cohort] only) — Taiho Pharmaceutical Co., Ltd.. Placebo has no active pharmacological mechanism; it serves as a control comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo [Ambulatory Cohort] only TARGET | Placebo [Ambulatory Cohort] only | Taiho Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo [Ambulatory Cohort] only CI watch — RSS
- Placebo [Ambulatory Cohort] only CI watch — Atom
- Placebo [Ambulatory Cohort] only CI watch — JSON
- Placebo [Ambulatory Cohort] only alone — RSS
Cite this brief
Drug Landscape (2026). Placebo [Ambulatory Cohort] only — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-ambulatory-cohort-only. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab